Keros Therapeutics, Inc.KROSNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+19.4%
5Y CAGR+30.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+19.4%/yr
vs +104.3%/yr prior
5Y CAGR
+30.9%/yr
Recent deceleration
Acceleration
-84.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $46.85M | +15.0% |
| 2024 | $40.75M | +17.0% |
| 2023 | $34.83M | +26.6% |
| 2022 | $27.52M | +29.0% |
| 2021 | $21.33M | +75.0% |
| 2020 | $12.19M | +282.9% |
| 2019 | $3.18M | +101.5% |
| 2018 | $1.58M | - |